KEY TAKE AWAYS

• To define and measure the Injectable drug delivery market and its various sub-segments with respect to types of systems, by mode of drug delivery, by therapeutics, by re-usability and by drugs delivered
• To identify the major drivers  and restraints of the market
• To identify and analyze comprehensively the market structure with respect to the factors influencing the market growth and industry specific challenges.
• To analyze the trends and forecasts of the injectable drug delivery market and its segments
• To identify the major stakeholders in the market and draw a competitive landscape for the market leaders
• To analyze the opportunities in the market for the stakeholders
• To strategically analyze micro markets with respect to their individual growth trends, future prospects and contribution to the total market
• To understand the regulatory framework, design criteria, pricing issues, threat from alternative methods available in the market.
• To analyze and forecast the revenues of market segments with respect to geographies (North America, Europe, Asia and Rest of the World
• To provide comprehensive analysis of the Top players in Injectable drug delivery market competitive scenario.

MARKETS COVERED

Rapid enhancements in drug discovery technologies leading to developments in proteomics and genomics have essentially had a greater impact on injectable drug delivery market. The number of injectable drugs to be introduced in medium to long term future is expected to be significant, to outweigh the threat from advanced alternative drug delivery technologies. Additionally increasing innovation in alternative technologies has extended the focus of injectable market participants on issues such injector design, convenience and painless modes of injectables and customization. The aligned pharmaceutical industries are actively collaborating with drug delivery companies to effectively target the patient concerns. Such strategic issues are driving the market significantly. The changing market trends, compels the industry participants to have extended clarity on market dynamics, increasing innovation from alternative technologies and threat from competitors in injectable drug delivery market to sustain their market position.

This report highlights the global injectable drug delivery market segmented as below

• Injectable systems (Sustained Release Injectable Systems, Needleless Systems Microneedle Injectors, Liposomal Systems/ PEGylation, Novel Injectable Technologies)
• By mode of drug delivery (Intradermal, Subcutaneous, Intramuscular, Intravenous, Intraosseous, intraperitoneal)
• By Therapeutics (Diabetes, Hepatitis C, Oncology, Rheumatoid Arthritis etc)
• By Reusability (Reusable, Disposable, Pre-filled, Custom)
• By Drug Classes (Antimuscarinics, Cytokines, Dopamine, Hematopoietics, Human Growth Hormone etc)

Our analysis would enable the industry players to get acquainted with the upcoming trends, opportunities and challenges in the market along with a detailed analysis of the sub-markets as well. The report will size all the sub markets and also give a detailed geographic split among the four major markets of North America, Europe, Asia and Rest of the World. We will provide market trends and forecasts supported by the drivers and inhibitors for each sub-segment. More than 100 market tables and top company profiles will provide a deeper insight into the market and the competitive landscape as well. We will categorize market tables into geographic regions, products, applications and bio-feed stocks.

In addition to the market size, data trends and forecasts, the report will also highlight key opportunity areas for the relevant stakeholders. We will analyze new product launches. In addition, we will analyze and profile key market developments of the top companies in this market and its sub-segments while drawing a competitive landscape for major markets and their sub segments.

STAKEHOLDERS

• Drug delivery technology – manufacturers, suppliers and dealers  
• Pharmaceutical & Biotech companies
• Healthcare providers
• Potential investors in the drug delivery technology (injectables) market

SAMPLE TABLES

Table of Content

1. Market Overview
   1.1. Evolution and value chain analysis of Injectable Market
   1.2. Injectable market Vs markets for other modes of drug delivery
        1.2.1. Market transitions (Short, medium and long term perspective)
        1.2.2. Reason for extending scope for injectables
        1.2.3. Technological innovations for injectables vs. alternative drug delivery system (micro-electromechanical devices, PEGylation, Nano-enabled injectables)
   1.3. Injector design criteria
   1.4. Novel drug/compound/Drug discovery technologies (proteomics, genomics etc) introduction demanding innovations in mode of drug delivery and future impacts 
   1.5. Legislations and Regulatory issues – Level of impacts of market
   1.6. Key market dynamics and opportunities
   1.7. Patent analysis
        1.7.1.  By Market participant
        1.7.2. By geography
   1.8. Strategic recommendations 
2. Market Summary - Total Injectable Drug Delivery Market
   (Key market trends and total market forecast)
   2.1. Key Market Drivers
   2.2. Key Restraints
   2.3. Key Opportunities  
3. Market Segmentation for Injectable Drug Delivery Market
   (Key drivers, restraints, opportunities, strategic analysis, market forecast for each of the markets)
   3.1. Injectable Drug Delivery Systems
        3.1.1. Sustained Release Injectable Systems
        3.1.2. Needleless Systems
        3.1.3. Microneedle Injectors
        3.1.4. Liposomal Systems/ PEGylation
        3.1.5. Novel Injectable Technologies
   3.2. Injectable – By Mode of Drug Delivery
        3.2.1. Intradermal
        3.2.2. Subcutaneous
        3.2.3. Intramuscular
        3.2.4. Intravenous
        3.2.5. Intraosseous
        3.2.6. Intraperitoneal
   3.3. By Therapeutics
        3.3.1. Acromegaly
        3.3.2. Age-Related Macular Degeneration
        3.3.3. Crohn's Disease
        3.3.4. Diabetes
        3.3.5. Hepatitis C
        3.3.6. Multiple Sclerosis
        3.3.7. Neutropenia
        3.3.8. Oncology
        3.3.9. Pain
        3.3.10. Psoriasis
        3.3.11. Rheumatoid Arthritis
        3.3.12. Other  (Emergency)
   3.4. Markets by Reusability
        3.4.1. Reusable
        3.4.2. Disposable
               3.4.2.1. Conventional
               3.4.2.2. Next-Generation Disposable Injection (Auto disable injectors and Auto injectors)
        3.4.3. Pre-filled
        3.4.4. Custom
   3.5. Drug Classes Delivered (Sample)
        3.5.1. Antimuscarinics
        3.5.2. Cytokines
        3.5.3. Dopamine
        3.5.4. Hematopoietics
        3.5.5. Human Growth Hormone
        3.5.6. Insulins and Antihyperglycemics
        3.5.7. Interferons
        3.5.8. Parathyroid Hormone
        3.5.9. Reproductive Hormones
        3.5.10. Serotonin Antagonists
        3.5.11. Sympathomimetics
        3.5.12. Others
4. Competitive Landscape
   4.1. Key market players (Market segment specific)
   4.2. Market position and market share (Depending on the nature of market)
   4.3. Market Strategies (Top tier companies strategy Vs regional player’s strategy)
   4.4. List of M&A and New Product Launch
   4.5. Other  recent strategic developments among the industry participants
5. Sample Company Profiles
   5.1. Alkermes
   5.2. ALZA
   5.3. Aradigm
   5.4. Bioject
   5.5. Enzon
   5.6. Ethypharm
   5.7. MacroMed
   5.8. Nektar Therapeutics
   5.9. QLT
   5.10. SkyePharm
   5.11. Others
6. Appendix
   6.1. List of patents
        6.1.1. U.S.
        6.1.2. Europe
        6.1.3. Japan.

MarketsandMarkets.com publishes about 120 report a year across 10 main industries. The reports are exhaustive reports with about 50 micro markets and product segments, about 80 to 100 market data summary tables, 50 short company profiles, market breakdown upto 5 levels, strategic and competitive landscape, patent overview of more than 300 patents.

MarketsandMarkets.com publishes about 120 report a year across 10 main industries. The reports are exhaustive reports with about 50 micro markets and product segments, about 80 to 100 market data summary tables, 50 short company profiles, market breakdown upto 5 levels, strategic and competitive landscape, patent overview of more than 300 patents.